Michael Carson

Director of Finance/CFO at NUVECTIS PHARMA, INC.

Net worth: 613 856 $ as of 2024-05-30

Health Technology

Commercial Services

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Ronald Bentsur	M	58	NUVECTIS PHARMA, INC.	4 years
Shay Shemesh	M	41	NUVECTIS PHARMA, INC.	4 years
Glenn Muir	M	65	NEURONETICS, INC.	7 years
Matt Kaplan	M	56	NUVECTIS PHARMA, INC.	3 years
Kenneth Hoberman	M	59	NUVECTIS PHARMA, INC.	3 years
James Oliviero	M	48	NUVECTIS PHARMA, INC.	3 years
Enrique Poradosu	M	58	NUVECTIS PHARMA, INC.	4 years
Aidan King	M	53	Xylocor Therapeutics, Inc. Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA.	3 years

Multi-company connection

Name	Gender	Age	Linked companies	Collaboration
Peter Donato	M	54	NEURONETICS, INC.	2 years
Ron Hunt	M	59	NEURONETICS, INC.	4 years
Paulina Hill	M	42	NEURONETICS, INC.	2 years
Gregory Harper	M	63	NEURONETICS, INC.	5 years
Paul Neff	M	72	NEURONETICS, INC.	9 years
Mark Demitrack	M	66	NEURONETICS, INC.	14 years
Daniel Guthrie	M	47	NEURONETICS, INC.	2 years
Cassie Hallberg	F	-	NEURONETICS, INC.	3 years
Yelena Tropsha	F	63	NEURONETICS, INC.	2 years
Rick Trank	M	-	NEURONETICS, INC.	1 years

Country	Connections	% of total
United States	12	66.67%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections